Building the First Icelandic Pangenome
Scientists at deCODE Genetics in Reykjavík have released the first Icelandic pangenome. This new map of genetic variation identifies millions of previously unseen markers across the human genome. By moving away from a single linear reference genome, researchers have removed the limitations of what is known as reference bias.
To build this tool, the team analyzed 698 chromosome sequences from 361 Icelandic individuals. They integrated this data into the existing international Human Pangenome Reference Consortium framework. The resulting reference, HPRC-ICE, provides a more accurate way to compare individual DNA against a wider range of known human variations. This process involved creating two new computational methods named Emblask and Weaver to handle the massive data processing requirements.
The Discovery of Hidden Parkinson’s Risk
The practical impact of this improved mapping is immediate. By applying HPRC-ICE to the whole-genome data of 57,630 Icelanders, the team identified 98.96 million genetic variants. This represents a 6.17% increase in detection compared to conventional mapping techniques. One specific discovery highlights the utility of this approach: a variant in the GBA1 gene that previous maps failed to resolve.
This GBA1 variant carries clinical weight. Individuals carrying this specific marker face a risk of early-onset Parkinson’s disease that is seven times higher than non-carriers. Because this variant was effectively camouflaged by older mapping techniques, it remained a blind spot for researchers for years. The team verified this association by remapping data from 429,193 participants in the UK Biobank, confirming that the link is not unique to Icelanders.
Why the Pangenome Matters for Future Medicine
The shift to pangenome mapping represents a change in how genetics functions as a field. For decades, researchers treated one standard DNA sequence as the default. This often obscured complex genetic regions where individuals possess high levels of natural diversity. By incorporating multiple haplotypes into the reference itself, scientists can now account for these variations.
This development does not translate into an immediate cure for Parkinson’s disease. Genetic associations represent only the starting point for biological research. However, the study confirms that the tools used to read our genetic code directly dictate what scientists can find. If a map is incomplete, the hidden variants remain invisible to clinical study.
Researchers also used the new map to identify a pathogenic variant in the CBS gene, which is linked to the inherited disorder homocystinuria. This serves as proof that the pangenome can reveal risks beyond Parkinson’s. As these methods mature, they will likely become a standard part of genomic analysis. The goal is to create a more accurate baseline for understanding health and disease across diverse populations, ensuring that no essential genetic clues are lost in the translation between raw data and medical insight.